Citation Impact
Citing Papers
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial
2014
Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases
2013
Genetics of inflammatory bowel disease: beyond NOD2
2017
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Safety and Efficacy of Treatment of Hepatitis C in Kidney Transplant Recipients With Directly Acting Antiviral Agents
2016
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
2017
Mucosal Healing in Inflammatory Bowel Disease: Where Do We Stand?
2010
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence
2011
Ulcerative colitis
2016 Standout
Ulcerative colitis
2020 Standout
Random forest Gini importance favours SNPs with large minor allele frequency: impact, sources and recommendations
2011
Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohnʼs Disease
2014
The global burden of IBD: from 2015 to 2025
2015 Standout
Towards personalized care in IBD
2013
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
2014
The use of fecal calprotectin and lactoferrin in patients with IBD. Review.
2013
Predictors of Long‐term Clinical and Endoscopic Remission in Children With Crohn Disease Treated With Infliximab
2019
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Slight Increases in the Disease Activity Index and Platelet Count Imply the Presence of Active Intestinal Lesions in C-reactive Protein-negative Crohn's Disease Patients
2014
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
2016
The revival of the Gini importance?
2018 Standout
Works of Wouter Van Moerkercke being referenced
Severe bridging fibrosis of the colon in a man with inflammatory bowel disease
2007
Molecular Reclassification of Crohn's Disease by Cluster Analysis of Genetic Variants
2010
Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
2011
Characteristics of Skin Lesions Associated With Anti–Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease
2015
405 High Infliximab Trough Levels are Associated With Mucosal Healing in Crohn's Disease
2010
539 Anti-TNF-Induced Skin Manifestations in IBD Patients: Role for Increased Drug Exposure?
2015